Latest News

Filters

Filter by tags: Leukemia Clear all tag filters

4 news articles found


Kazak President Kassym-Jomart Tokayev, in a wide-ranging state-of-the nation has proposed holding a referendum on the issue of NPP construction or refusal to build a nuclear power plant to a national referendum. The Ministry of energy said that, together with interested state bodies, Deputies of Parliament, experts in this field, and public activists, it will consider all issues related to the implementation of the President's instructions, work out other aspects and inform the public about this work.

Date: Wednesday, 06 September 2023
Original article: neimagazine.com/news/newskazakhstan-to-hold-referendum-on-nuclear-power-11122035

TerraPower Isotopes and Belgian joint venture PanTera have announced a collaboration to increase the global availability of actinium-225 (Ac-225), while Arizona-based Serva Energy has developed a new research reactor-based production method to ramp up the supply of the rare radioisotope.

Date: Wednesday, 28 June 2023
Original article: world-nuclear-news.org/Articles/Nuclear-innovation-companies-in-new-Ac-225-initiat

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023

Doses received by children and adults from the same source of ionizing radiation can have differing impacts, and therefore, should be considered separately in order to predict risk following exposure more accurately for children, according to the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR)'s report "Effects of radiation exposure of children" presented at the United Nations headquarters in New York.

Date: Tuesday, 29 October 2013
Original article: neimagazine.com/news/newsrisk-following-exposure-to-radiation-differs-for-adults-and-children-says-unscear-report